And very son FOMO (the fear of missing out) will kick in.
I have a number of investments that are due to produce serious results before the end of the financial year (30 June). Let's have a look at them, in alphabetical order (I am not offering financial advice, just a commentary on where I am at with my investments):
1AI - actually, the result is due (probably) in July, but there is a chance that there will be an announcement sooner than that. These guys are doing amazing things with AI in the biomed sphere and will be a long-term winner )in my opinion). The next result should see a gain of at least 50% in their share price. In fact, as I write this their quarterly report has been released. After a quick read I am pleased to not have to change anything I just said. An announcement is due BY Q3. Happy days, only 2 months to go for that one.
BOT - Massive result due in late June. This should beest the share price by 150% from where it is now. These guys are also doing great and have a really solid follow-on. On product they do have up their sleeve is a synthetic cannabinoid, and that suggests that they might benefit from sharing a beer with 1AI to see if the two companies can work together. If that happens, watch out! Also, BOT is a takeover yatget by big Pharma. This particular space will become very exciting very quickly.
DTR 1 See my last 2 posts about this company. Anything COULD happen, but I feel that nothing will happen until at least October. When the others come through, this might be a good one to top up on.
DXB - like BOT, this is another WOW! stock. However, there are no clear dates on this one. While BOT is definately late-June, DXB is anytime. They are working on licensing deals for the USA and China, both of which are massive company-makers. This stock will probably increase 100% (a good time to sell) before retreating by about 30% (a good time to buy back in) before incresing again. And there are some interesting people who are comparing DXB's share price movements to that of NEU which went from where DXB is now (32 cents) to around $26 in less than 2 years. The imminent news about licensing deals is already steadily driving the share price up.
And that's where I am at and why.
Comments
Post a Comment